biomar and Infinitec join forces to develop a dermocosmetic antiácne
-national biotechnology two marketed a new extract of natural origin in the world
-the Leonese company discovers an excerpt in the cosmetic properties with sea urchin
Madrid-Barcelona-León, may 2012.- the company Spanish bioteconológica Biomar Microbial Technologies has just announced that it has signed an agreement with the Catalan biotech company Infinitec assets to develop a dermocosmetic treatment of natural origin with disinfectant properties and acne.
This extract called in their clinical trials AD037 is patented by Biomar Microbial Technologies and is currently awaiting the latest clinical trials to have its brand name that will be launched into the market.
According to Antonio Fernández, Counsellor delegate of Biomar Microbial technologies, this extract is obtained from the fermentation of a marine microorganism that comes from a sea urchin and in laboratory tests for three years has shown the maximum safety and efficacy complying with current regulations in this area have proven that this natural product has very potent anti-infective properties for eliminate the bacteria in Acne (propionbacterium acnes). In the trials get improve without side effects and maximum tolerability acne lesions. He is a principle free of AHA and aromas which respect the Ph of the skin ” says Antonio Fernandez.
Sus investigadores señalan que este extracto dermocosmético se comercializará con la presentación de crema-tópica de uso externo y ha demostrado su eficacia para tratar las lesiones y manifestaciones externas en la piel con tendencia acnéica. The Catalan company Infinitec assets team is currently finalizing all evidence of efficacy, safety and toxicity contained in European legislation (11/1/2010) that regulate the production of dermocosméticos.
Two biotechnology national pioneers in cosmetic skincare
This commercial agreement between the Leonese biotechnology company Biomar and biotechnological Catalan Infinitec this dermocosmetic product will be available in 44 different countries.
The company Biomar will deal with production on a large scale of this extract optimizing all methods to streamline its production with maximum guarantees. And, for its part, the Catalan company Infinitec-assets will perform marketing worldwide taking advantage of its dealer network in areas such as China, Japan or USA.
In the view of Antonio Fernández, Infinitec assets company seems a partner right by having a very consolidated commercial international network in the distribution of dermocosmetic products. For Biomar international market represents about 95% of our billing ”, explains Antonio Fernández.
For its part, Alfonso Hidalgo, CEO of Infinitec assets, points out that it has selected Biomar Microbial Technologies for two reasons. On the one hand, by the quality of the production processes of its factory where they just make an investment of two million euros and meets the standards of quality GMP international required to produce drugs on a large scale. And, secondly, for the academic quality of its biologists and researchers with extensive international experience familiar with more stringent standards of quality and safety in the international markets ”, Hidalgo explains.
According to Alfonso Hidalgo this product has just presented as a novelty at the fair In Cosmetics in Barcelona. After its release, the first three years of its marketing, hope to get a few sales exceeding 200,000€ ”, clarifies Hidalgo.
